TIGIT-CD155 interactions in melanoma: a novel co-inhibitory pathway with potential for clinical intervention

Inozume et al. describe a novel immunosuppressive mechanism in melanoma that is triggered by the interaction between CD155 (expressed by melanomas) and T-cell Ig and ITIM domain (TIGIT) (expressed by tumor infiltrating lymphocytes). This pathway exists in addition to the "classical" co-inh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mahnke, Karsten (VerfasserIn) , Enk, Alexander (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 4 January 2016
In: The journal of investigative dermatology
Year: 2016, Jahrgang: 136, Heft: 1, Pages: 9-11
ISSN:1523-1747
DOI:10.1016/j.jid.2015.10.048
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jid.2015.10.048
Volltext
Verfasserangaben:Karsten Mahnke and Alexander H. Enk

MARC

LEADER 00000caa a2200000 c 4500
001 1698699034
003 DE-627
005 20220818094910.0
007 cr uuu---uuuuu
008 200522s2016 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jid.2015.10.048  |2 doi 
035 |a (DE-627)1698699034 
035 |a (DE-599)KXP1698699034 
035 |a (OCoLC)1341326254 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Mahnke, Karsten  |e VerfasserIn  |0 (DE-588)1022899147  |0 (DE-627)717328007  |0 (DE-576)366144383  |4 aut 
245 1 0 |a TIGIT-CD155 interactions in melanoma  |b a novel co-inhibitory pathway with potential for clinical intervention  |c Karsten Mahnke and Alexander H. Enk 
264 1 |c 4 January 2016 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.05.2020 
520 |a Inozume et al. describe a novel immunosuppressive mechanism in melanoma that is triggered by the interaction between CD155 (expressed by melanomas) and T-cell Ig and ITIM domain (TIGIT) (expressed by tumor infiltrating lymphocytes). This pathway exists in addition to the "classical" co-inhibitory PD-1-PD-L1 pathway. Hence, the combinatorial blockage of both pathways by specific antibodies resulted in the greatly enhanced effector function of melanoma-specific cytotoxic T cells. Given that CD155-TIGIT signaling exerts potent inhibitory action in different subsets of immune cells and that CD155 is expressed broadly in several tumor entities, this report points toward a novel and promising therapeutic strategy to combine different checkpoint blocking agents for greater success in antitumor therapy. 
650 4 |a Biomarkers, Tumor 
650 4 |a Humans 
650 4 |a Receptors, Immunologic 
650 4 |a Receptors, Virus 
650 4 |a RNA, Small Interfering 
700 1 |a Enk, Alexander  |d 1963-  |e VerfasserIn  |0 (DE-588)1032757140  |0 (DE-627)739272535  |0 (DE-576)166173517  |4 aut 
773 0 8 |i Enthalten in  |t The journal of investigative dermatology  |d Amsterdam : Elsevier, 1938  |g 136(2016), 1, Seite 9-11  |h Online-Ressource  |w (DE-627)320457990  |w (DE-600)2006902-9  |w (DE-576)09114289X  |x 1523-1747  |7 nnas  |a TIGIT-CD155 interactions in melanoma a novel co-inhibitory pathway with potential for clinical intervention 
773 1 8 |g volume:136  |g year:2016  |g number:1  |g pages:9-11  |g extent:3  |a TIGIT-CD155 interactions in melanoma a novel co-inhibitory pathway with potential for clinical intervention 
856 4 0 |u https://doi.org/10.1016/j.jid.2015.10.048  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200522 
993 |a Article 
994 |a 2016 
998 |g 1032757140  |a Enk, Alexander  |m 1032757140:Enk, Alexander  |d 910000  |d 911300  |e 910000PE1032757140  |e 911300PE1032757140  |k 0/910000/  |k 1/910000/911300/  |p 2  |y j 
998 |g 1022899147  |a Mahnke, Karsten  |m 1022899147:Mahnke, Karsten  |d 910000  |d 911300  |e 910000PM1022899147  |e 911300PM1022899147  |k 0/910000/  |k 1/910000/911300/  |p 1  |x j 
999 |a KXP-PPN1698699034  |e 3669947752 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"disp":"TIGIT-CD155 interactions in melanoma a novel co-inhibitory pathway with potential for clinical interventionThe journal of investigative dermatology","note":["Gesehen am 16.02.16"],"pubHistory":["1.1938 -"],"recId":"320457990","name":{"displayForm":["Society for Investigative Dermatology ; European Society for Dermatological Research"]},"origin":[{"dateIssuedDisp":"1938-","publisherPlace":"Amsterdam ; Oxford [u.a.] ; [Erscheinungsort nicht ermittelbar] ; Basingstoke [u.a.]","publisher":"Elsevier ; Blackwell ; Wiley-Blackwell ; Nature Publishing Group","dateIssuedKey":"1938"}],"part":{"extent":"3","year":"2016","issue":"1","volume":"136","text":"136(2016), 1, Seite 9-11","pages":"9-11"},"titleAlt":[{"title":"an international journal for research in cutaneous biology"}],"title":[{"title":"The journal of investigative dermatology","title_sort":"journal of investigative dermatology"}],"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"role":"isb","display":"Society for Investigative Dermatology"}],"id":{"issn":["1523-1747"],"zdb":["2006902-9"],"eki":["320457990"]},"language":["eng"]}],"person":[{"family":"Mahnke","display":"Mahnke, Karsten","given":"Karsten","role":"aut"},{"role":"aut","given":"Alexander","display":"Enk, Alexander","family":"Enk"}],"title":[{"title":"TIGIT-CD155 interactions in melanoma","subtitle":"a novel co-inhibitory pathway with potential for clinical intervention","title_sort":"TIGIT-CD155 interactions in melanoma"}],"physDesc":[{"extent":"3 S."}],"origin":[{"dateIssuedDisp":"4 January 2016","dateIssuedKey":"2016"}],"id":{"doi":["10.1016/j.jid.2015.10.048"],"eki":["1698699034"]},"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1698699034","note":["Gesehen am 22.05.2020"],"name":{"displayForm":["Karsten Mahnke and Alexander H. Enk"]}} 
SRT |a MAHNKEKARSTIGITCD1554201